The EU will not extend the COVID-19 vaccines export transparency and authorisation mechanism, which expires on 31 December 2021. This means that, as of 1 January 2022, vaccine producers will no longer have to request an authorisation for the export of vaccines outside the EU. Transparency of exports will continue to be ensured through a new monitoring mechanism that will provide the European Commission with timely, company-specific vaccine export data. The Commission will continue to monitor the ongoing epidemiological situation in order to take appropriate measures if necessary.
This decision is part of broader EU efforts to facilitate the widest and fastest production and equitable distribution of COVID-19 vaccines that the world urgently needs: